Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Jan;112(1):11.
doi: 10.5935/abc.20180269.

Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia

[Article in English, Portuguese]
Affiliations
Editorial

Synergy of Rapamycin and Cyanoacrylate in Reducing Intimal Hyperplasia

[Article in English, Portuguese]
Marcia Kiyomi Koike. Arq Bras Cardiol. 2019 Jan.
No abstract available

PubMed Disclaimer

Comment on

References

    1. de Vries MR, Quax PHA. Inflammation in vein graft disease. Front Cardiovasc Med. 2018;5:3–3. - PMC - PubMed
    1. Gooch KJ, Firstenberg MS, Shrefler BS, Scandling BW. Biomechanics and mechanobiology of saphenous vein grafts. J Biomech Eng. 2018;140(2) 020804-020804-16. - PubMed
    1. Mylonaki I, Allain E, Strano F, Alle'mann E, Corpataux J-M, Meda P, et al. Evaluating intimal hyperplasia under clinical conditions. Interact Cardiovasc Thorac Surg. 2018;27(3):427–436. - PubMed
    1. Chen HL, Liu K, Meng XY, Wen XD, You QS. Local application of rapamycin inhibits vein graft restenosis in rabbits. Transpl Proc. 2011;43(5):2017–2021. - PubMed
    1. Skalsky I, Szarszoi O, Filova E, Parizek M, Lytvynets A, Maluskova J, et al. A perivascular system releasing sirolimus prevented intimal hyperplasia in a rabbit model in a medium-term study. Int J Phamaceutics. 2012;427(2):311–319. - PubMed